Inovio Partner Announces Completion Of Phase I DNA Vaccine Study

Inovio Biomedical Corporation (NYSE Amex:INO), a leader in DNA vaccine design, development and delivery, announced today that its partner Tripep AB of Sweden has completed its phase I clinical study of its ChronVac-C hepatitis C virus DNA vaccine delivered using Inovio’s electroporation technology. The study established the safety and tolerability of this therapy, with vaccine-induced immune responses and transient effects on the serum levels of hepatitis C virus in these chronically infected patients providing proof-of-concept of DNA vaccines delivered using electroporation…

Go to Source

People who read this also read

• Tripep: The ChronVac-C(R) Study Has Been Successfully Completed With Good Safety And Favorable Clinical Data
  All samples from the 12 patients with chronic Hepatitis C genotype 1 treated with Tripep's therapeutic vaccine ChronVac-C® have now been collected. The treatment was found to be safe, immunogenic and had transient effects on the serum levels of hepatitis C virus. This provides a proof-of-concept for...
• Phase I Study Of Preventive HIV Vaccine Shows Improved Immune Responses When The Vaccine Is Delivered By Electrical Impulses
  A Phase 1 study of a preventive HIV vaccine testing a novel delivery mechanism known as electroporation - the use of electrical pulses to increase the immune responses elicited by DNA vaccines - was recently completed in New York City. The results show that TriGrid™, a technology developed by Ichor ...
• NVHR: New Data Finding Fewer Than 1 In 5 Hepatitis C Patients Receiving Antiviral Therapy Is ‘Wake-Up Call’ For Washington
  New peer-reviewed data finding that fewer than one-fifth of the nearly 4 million Americans infected with chronic hepatitis C virus have received anti-viral therapy in recent years should be a wake-up call that Congress needs to move urgently on bipartisan legislation to support new state-based detec...
• Progression of Liver Disease
  There are many different types of liver disease. But no matter what type you have, the damage to your liver is likely to progress in a similar way. Whether your liver is infected with a virus, injured by chemicals, or under attack from your own immune system, the basic danger is the same – that you...
• Chronic Liver Diseases
  Liver diseases are damaged the function of hapetocytes, it may causes hepatocellular necrosis, fibrosis, and regeneration with nodule formation. Chronic liver disease in which liver damage slowly by process and persisting over long time.It means it act as slow poison for healthy human body. It is...